Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6-$9.7 Million, Up 3-4% Year-over-Year

Stock Information for SANUWAVE Health Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SANUWAVE Health Inc.

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3-$13.4 Million, Up 29-30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
Sanuwave Announces Q3 FY2025 Financial Results
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.